Poor adherence and persistence to sodium glucose co-transporter 2 inhibitors in real-world settings: Evidence from a systematic review and meta-analysis.

Richard Ofori-AsensoBerhe W SahleKen Lee ChinMohsen MazidiZanfina AdemiMarie Louise De BruinDanny Liew

Published in: Diabetes/metabolism research and reviews (2020)

Real-world adherence and persistence to SGLT2 inhibitors is poor. Hence, targets for improving treatment adherence and persistence need to be identified and appropriate interventions implemented.

Keyphrases

glycemic control
physical activity
type diabetes
adipose tissue
insulin resistance